The Lancet Summit: Inflammation and Immunity in Disorders of the Brain and Mind

November 15-17, 2018 | NH Collection Barcelona Tower, Hospitalet de Llobregat, Barcelona, Spain

Join The Lancet Neurology and The Lancet Psychiatry for a landmark conference in the exciting clinical field of immunological disorders of the brain and mind. This developing area not only presents neurologists and psychiatrists with potential new treatments for their patients, but also demands a rethink of the boundaries of the two disciplines, and how they will move forward together. By bringing together both professions, this conference will provide vital education as well as launching future research and clinical collaborations.

The programme will cover recent, ongoing, and future research in the developing field of neuroimmunological disease including recent research findings regarding mechanisms of disease, and the translation of this knowledge into treatment, diagnosis, and the prevention of neurological and psychiatric disorders.

The event will have a translational focus, starting with the basic science of immunology and the brain, and then moving into the roles these systems play in neuropsychiatric health and disease, and ending with a clinically-focused debate on screening and treatment.

We welcome poster presentations.

Topics include:

• Autoimmunity in the central nervous system
• The blood-brain barrier in neurological and psychiatric illness
• The immune system and disorders of the brain and mind
• Screening for and managing neuroimmunological disorders in clinical practice

Abstract Submission Deadline: May 18, 2018

Submit AbstractRegister NowView Programme
Speakers include
  • Sergio Baranzini, University of California San Francisco, USA
    Premysl Bercik, McMaster University, Canada
    Amit Bar-Or, University of Pennsylvania, USA
    Lisa Boulanger, Princeton University, USA
    Josep Dalmau, University of Barcelona, IDIBAPS, and ICREA, Spain and University of Pennsylvania, USA
    Richard Daneman, University of California San Diego, USA
    Betty Diamond, The Feinstein Institute for Medical Research, USA
    Wayne Drevets, Johnson & Johnson, Inc, USA
    Nicolas Glaichenhaus, CNRS/University Nice Sophia Antipolis, France
    Michael Heneka, University of Bonn, Germany
    Reinhard Hohlfeld, Ludwig Maximilians University of Munich, Germany
    Golam M Khandaker, University of Cambridge, UK
    Marion Leboyer, University Paris-Est Créteil, France
    Belinda Lennox, Oxford University, UK
    Emmanuel Mignot, Stanford University, USA
    V. Hugh Perry, University of Southampton, UK
    Tom Pollak, Kings College London, UK
    Marco Prinz, University of Freiburg, Germany
    Joan Santamaria, University of Barcelona, Spain
    Akira Sawa, Johns Hopkins University Hospital, USA
    Michal Schwartz, Weizmann Institute of Science, Israel
    Iris Sommer, University Medical Center Groningen, The Netherlands
    Hartmut Wekerle, Max Plank Institute of Neurobiology, Germany
    Shen-Ying Zang, Rockefeller University, USA

Conference Committee
  • Elena Becker-Barroso, Editor, The Lancet Neurology, UK
  • Niall Boyce, Editor, The Lancet Psychiatry, UK
  • Josep Dalmau, University of Barcelona, IDIBAPS, and ICREA, Spain and University of Pennsylvania, USA
  • Francesc Graus, University of Barcelona, Spain
  • Marion Leboyer, University Paris-Est Créteil, France
  • Akira Sawa, Johns Hopkins University Hospital, USA
Supporting Publications

Organised by
 
  • Elsevier
  • TLP
  • TLN
Exhibitors
 
  • Encephalitis Society
  • Treating Autism
Sponsors
 
  • Encephalitis Society
  • Treating Autism